US News & World Report - Genetic Tests Predict Response to Warfarin
March 11, 2008
Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of the anti-clotting drug, researchers report.
Thank you for helping us expand participation in this important work! We rely on people with lived experience of ALS to help ensure research reflects the needs and priorities of the community. Please use the form below to nominate someone whose experiences, perspectives, and interests may make them a strong contributor to an ALS Research Working Group. No scientific or medical background is required.
